Melinta Therapeutics to Give New Presentations on Antibiotics Portfolio and Pipeline at IDWeek™ 2018

World News: . []

NEW HAVEN Conn Sept 24 2018 GLOBE NEWSWIRE -- Melinta Therapeutics Inc. (NASDAQ: MLNT a commercial-stage company discovering developing and commercializing novel antibiotics to treat serious bacterial infections today announced that e ight pr...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Monday 24th September 2018

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us